The Pharmaceutical Education & Research Institute, Inc. (Peri) Jun 2006 - Jun 2012
Faculty
Unitedhealth Group 2008 - 2012
Senior Medical Director Health Economics and Outcomes Research, Oncology and Biologics
I3 Research 2008 - 2011
Senior Medical Director
Kanisa Pharmaceuticals 2007 - 2008
Chief Medical Officer and Senior Vice President Clinical Development
Kyowa Pharmaceutical, Inc. 2005 - 2007
Vice President Clinical Development
Education:
New York University 1968 - 1970
Master of Science, Masters, Physiology
Rush Medical College of Rush University Medical Center
Doctor of Medicine, Doctorates, Medicine
Skills:
Oncology Pharmaceutical Industry Clinical Research Medical Affairs Biotechnology Clinical Development Clinical Trials Drug Development Outcomes Research Health Economics Regulatory Affairs Lifesciences Cro Medicine Pharmacovigilance Hematologic Malignancies
12264 El Camino Real Suite 300, San Diego, CA 92130 (609)3692237 (Phone)
SIDHU AMARPAUL S MD OFFICE 412 W Carroll Ave Suite 210, Glendora, CA 91741 (626)3355265 (Phone), (626)3355293 (Fax)
Certifications:
Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School Rush University Graduated: 1977 Medical School Los Angeles Co Hosp Graduated: 1977 Medical School Usc Med Ctr Graduated: 1977 Medical School Cedars-Sinai Med Ctr-Ucla Graduated: 1977
Erard Gilles - Bridgewater NJ, US Lars-Axel Sternas - Verona NJ, US Ovid Trifan - Bridgewater NJ, US Helgi van de Velde - Beerse, BE April Teitelbaum - Doylestown PA, US
Assignee:
Pharma Mar, S.A. Sociedad Unipersonal - Madrid
International Classification:
A61K 9/127 A61P 35/00 A61K 31/704 A61K 31/4995
US Classification:
424450, 514 34, 514250
Abstract:
A method of treating the human body for cancer comprises administering an effective therapeutic amount of a Pegylated Liposomal form of the anthracycline Doxorubicin (“PLD”), in combination with an effective therapeutic amount of ET-743